Implementation of Red Blood Cell Transfusion Recommendations in the Pediatric Intensive Care Unit
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Stanford University
- Study ID
- NCT07108374
- Status
- Enrolling By Invitation
Conditions
- Red Blood Cell Transfusions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Implementation strategies to increase use of transfusion recommendations — OTHERFive implementation strategies will be employed in this study to enhance use of the blood transfusion recommendations. These include 1) building consensus, 2) provider education, 3) identifying and empowering champions ,4) use of computerized clinical decision support tools, and 5) provide quantitative metric-based feedback. Strategies 1-3 will occur prior to initiation of CCDS tools. All patients admitted to the PICU following the date of CCDS tool initiation will be considered to be part of the post-implementation phase. The investigators will collect data from the EHR on CCDS use and conduct provider surveys and interviews following CCDS tool initiation. Surveys and interviews will be both be conducted at 6 and 12 months post-CCDS tool initiation. Process and outcomes measures will be assessed before an after use of the implementation strategies.
Study Details
Evidence demonstrates that the risks of red blood cell transfusions outweigh benefits in many patients who are hospitalized in the pediatric intensive care unit with increased risk of organ dysfunction, infection, delirium, and death. Recommendations have been developed to restrict transfusion in patients who are unlikely to benefit; however, these recommendations have not been consistently adopted into clinical practice. This study examines use of targeted efforts (implementation strategies) to improve implementation of the recommendations, with a goal of reducing unnecessary transfusions and improving patient outcomes in critically ill children.
Key Dates
- Start date
- Nov 30, 2024
- Status verified
- Jul 2025
- Primary completion
- Dec 31, 2026
- Completion
- Feb 1, 2027
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Primary Outcome Measure
Mean change from baseline in transfusion recommendation adherence at 18 months (evidence-based threshold alert) [ Time Frame: 18 months ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Lucile Packard Children's Hospital, Stanford University | Palo Alto | California | 94304 | - |
| The Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | - |